Rhodotorula Species Test

Most people will go their whole lives without hearing about Rhodotorula. It is a red to orange yeast that lives in soil, water, on damp surfaces, on your skin, and sometimes in your gut. For the average healthy person, finding a little of it on a stool test is usually unremarkable. For someone with a compromised immune system, a central venous line, or persistent skin and gut symptoms, it can matter more.

This test looks for Rhodotorula species in your stool. It is part of the fungal side of your microbiome, an area that standard gut testing has historically ignored in favor of bacteria. The number on your report tells you whether Rhodotorula is present and how much there is, which can help you spot fungal patterns that conventional bacterial-focused stool tests miss.

What Rhodotorula Actually Is

Rhodotorula species are budding yeasts, meaning they are single-celled fungi that reproduce by pinching off new cells. The genus contains roughly 15 closely related species, with R. mucilaginosa, R. glutinis, and R. minuta being the ones most often identified in humans. They produce carotenoid pigments, which is why they look pink or coral on a culture plate.

Rhodotorula is best thought of as an environmental yeast that hitches a ride. It lives on damp surfaces, plant material, and in water, and from there it lands on skin, mucous membranes, and the gut. It has been detected as part of the normal oral fungal community in adults, and shows up as a minority component of the skin and vaginal fungal communities.

The Gut Connection

The gut research on Rhodotorula is early, but two findings stand out. In a study of infants with atopic dermatitis (the medical name for persistent eczema), babies whose skin condition stuck around had higher activity of Rhodotorula proteins in their stool. The researchers identified specific fungal proteins that may act as allergens or interact with the immune system through fat-based signaling. This does not prove Rhodotorula causes eczema, but it suggests gut Rhodotorula activity may be one of several fungal factors involved in persistent allergic skin disease.

A separate body of work on gut fungi and Alzheimer's disease found that Rhodotorula mucilaginosa was reduced in the stool of people with the disease and that lower levels were linked to higher inflammation as measured by a protein called TNF-alpha (a signaling molecule your immune system releases during inflammation). This is observational and does not mean low Rhodotorula causes brain disease, only that the fungal community in the gut seems to shift in people with Alzheimer's.

When Rhodotorula Becomes Dangerous

Most of the published research on Rhodotorula in humans is not about gut levels at all. It is about what happens when this yeast escapes its usual home and gets into the bloodstream, the central nervous system, or the eye. These bloodstream studies do not directly tell you what your stool level means, but they explain why Rhodotorula gets attention in the first place.

A systematic review of 248 patients with invasive Rhodotorula infections found that the most common scenarios were bloodstream infections, meningitis (infection of the lining around the brain), eye infections, and infection of the abdominal lining in people on peritoneal dialysis. The single biggest risk factor was having a central venous catheter, which is a long-term IV line. Cancer, low white blood cell counts, recent antibiotic use, and azole antifungal prophylaxis (a class of drugs that does not work against Rhodotorula) also stood out.

Why does the antifungal piece matter? Rhodotorula is intrinsically resistant to fluconazole and the echinocandin class of antifungals. When patients on these drugs develop a fungal infection, Rhodotorula is one of the yeasts that can slip through because the medication never had any effect on it in the first place. The standard treatment for invasive disease is amphotericin B, often combined with flucytosine, along with removing the infected line or device.

Reference Ranges and What Counts as Detected

There are no nationally agreed-upon reference ranges for gut Rhodotorula. The published research on Rhodotorula does not define a number above which colonization becomes pathological and below which it is normal. Most stool testing labs report the result either as detected versus not detected, or as a colony forming unit count (CFU/g stool) compared to the lab's own reference population. Treat the result as a yes-or-no signal first and a quantity second.

The ranges below are illustrative orientation drawn from how clinical labs commonly tier yeast results in stool. They are not universal targets, and your lab may use different cutpoints or different units. Compare your number against your own lab's reference range, and against your own prior results from the same lab.

Because Rhodotorula is widespread in the environment and on skin, a positive result by itself does not mean infection. Clinical context, symptoms, and immune status all factor in.

Tracking Your Trend

A single stool test is a snapshot. Fungal communities in the gut shift with diet, antibiotic and antifungal use, travel, illness, and stress. A one-time positive does not necessarily mean Rhodotorula has colonized your gut long-term, and a one-time negative does not rule it out. Tracking the trend matters more than any single reading.

If you are using this test as part of broader gut mycobiome work, get a baseline, then retest in 3 to 6 months if you are actively changing your diet, taking antifungals, or recovering from antibiotics. After that, an annual check is reasonable for proactive monitoring. If you have ongoing immune compromise or a relevant clinical situation, retest more often based on your physician's guidance.

When Results Can Be Misleading

• Misidentification by older lab methods: standard yeast identification kits have mislabeled other fungi as Rhodotorula and vice versa. In one airway study, nearly half of isolates initially called Rhodotorula were actually a different mold called Exophiala dermatitidis when confirmed by genetic sequencing. Labs using mass spectrometry (MALDI-TOF) or DNA sequencing are more reliable.
• Recent antifungal use: if you have been on fluconazole or an echinocandin recently, the gut fungal community may be reshaped in ways that favor Rhodotorula because those drugs do not kill it. The reading reflects a temporarily disturbed mycobiome rather than your baseline.
• Recent broad-spectrum antibiotics: wiping out gut bacteria opens space for fungi to expand. A high Rhodotorula reading shortly after antibiotics may not reflect a steady state.
• Skin and environmental contamination: Rhodotorula is common on skin and in damp environments. Sloppy stool collection can introduce environmental yeast that did not actually come from your gut.

What to Do With an Abnormal Result

If Rhodotorula shows up at a level your lab flags as elevated, the first step is context, not panic. Are you having gut symptoms? Persistent skin issues like eczema? Are you immunocompromised, on long-term steroids, or living with a central line? An isolated positive in an otherwise healthy person with no symptoms is usually a microbiome curiosity rather than a clinical problem.

If you do have symptoms or risk factors, the next step is a fuller workup rather than self-treatment. That can include a repeat stool test to confirm the finding, a broader gut microbiome and inflammation panel, and a conversation with a clinician familiar with fungal infections, such as an infectious disease specialist or a functional medicine physician. If you are immunocompromised and develop fever, new neurologic symptoms, or eye symptoms, treat that as urgent rather than something to track with another stool test.